Shubham Sharma | Pharmacology | Best Researcher Award

Shubham Sharma | Pharmacology | Best Researcher Award

Dr Shubham Sharma, Pfizer, United States

Dr. Shubham Sharma is a leading computational modeler with 8+ years of expertise in theoretical materials science, physics, and chemistry. Holding a Ph.D. in Chemical & Environmental Engineering from Brown University (2021), he specializes in atomistic modeling and solid-form design, notably working at Pfizer where he leads drug de-risking efforts. His research in catalysis, electrochemistry, and crystal structure predictions has earned him over 10 Pfizer Bravo awards. Dr. Sharma’s groundbreaking work is recognized globally, including invited talks at major conferences, advancing both pharmaceutical and renewable energy applications. πŸ’»πŸ”¬πŸ’Šβš‘

Publication Profile

Google Scholar

Education

This individual holds a PhD in Chemical & Environmental Engineering from Brown University, USA (2016-2021) πŸŽ“, where they conducted research under the guidance of Andrew A. Peterson πŸ§‘β€πŸ”¬. Their academic journey began with a Bachelor of Technology (B. Tech) in Chemical Engineering from the Heritage Institute of Technology, India (2012-2016) πŸ› οΈ. With a strong foundation in chemical engineering, they have pursued advanced studies focusing on environmental solutions and sustainability 🌍. Their education showcases a dedication to addressing global environmental challenges through innovative engineering approaches and cutting-edge research πŸŒ±πŸ“˜.

Work Experience

Currently serving as a Senior Scientist in Computational Materials Science at Pfizer Inc. (July 2022 – present) πŸ§‘β€πŸ”¬, this individual leads the Solid Form Design Center (SFDC) focused on de-risking potential drug molecules through advanced statistical and quantum mechanical modeling πŸ’Š. They contributed to the success of Zavegepant (Zavzpretβ„’) and Rimegepant (Nurtecβ„’) 🌟. As a core member of the Crystal Structure Prediction team, they specialize in electronic structure theory, density functional theory, and atomistic modeling 🧬. They also collaborate with global industrial and academic partners, lead multiple research proposals, and mentor colleagues in computational science πŸ”¬πŸ’».

Selected conference presentations

Sharma has delivered numerous invited talks and presentations globally 🌍. In 2024, they presented on multi-polymorphic systems at the Crystal Form Consortium Symposium (UK) and computational strategies in pharmaceutical research at UConn (US) and IISER (India) πŸ§ͺ. Sharma also discussed electrocatalysis at the 8th Global Webinar on Materials Science & Engineering in 2023 πŸ§‘β€πŸ«. Other notable presentations include de-risking medicines at AAPS NERDG (2024) and several studies on oxygen reduction reactions and catalytic properties at AIChE, NECS, ECS, and MRS conferences 🎀. Their work spans computational modeling and applied research in materials science and electrocatalysis βš›οΈ.

Research Focus

The research focus of Sharma spans electrochemistry, catalysis, and materials science. Sharma investigates the design and stability of catalysts, particularly Pt-based and CoPt alloys, for fuel cells and oxygen reduction reactions (ORR) βš‘οΈπŸ”‹. His work includes dynamic stability, reaction barriers, and potential-controlled reactions, using advanced techniques like density functional theory (DFT) and experimental-theoretical integration. He also explores solid form derisking in pharmaceuticals πŸ’Š and carbon electrodes in redox flow batteries. Sharma’s studies contribute to cleaner energy and advanced catalytic systems πŸŒπŸ”¬, emphasizing electrochemical stability and performance improvement in energy devices.

 

Publication Top Notes

Hard-magnet L10-CoPt nanoparticles advance fuel cell catalysis

Anisotropic Strain Tuning of L10Β Ternary Nanoparticles for Oxygen Reduction

Face-centered tetragonal (FCT) Fe and Co alloys of Pt as catalysts for the oxygen reduction reaction (ORR): A DFT study

Ordered CoPt oxygen reduction catalyst with high performance and durability

Metal dissolution from first principles: Potential-dependent kinetics and charge transfer

Assessment of carbon monoxide exposure in roadside food-vending shanties using coal cookstoves in Kolkata, India

Dynamic stability of Pt-based alloys for fuel-cell catalysts calculated from atomistics

Conclusion

Dr. Shubham Sharma’s innovative research in computational modeling and materials science, alongside his leadership in both academic and industrial collaborations, makes him an exceptional candidate for the Best Researcher Award. His contributions have not only advanced pharmaceutical drug design but also impacted renewable energy research, marking him as a distinguished leader in his field.

Vahideh Mohammadzadeh | Pharmacology Award | Best Researcher Award

Dr. Vahideh Mohammadzadeh | Pharmacology Award | Best Researcher Award

Dr. Vahideh Mohammadzadeh, mashhad university of medical science, Iran

Dr. Vahideh Mohammadzadeh is a Ph.D. student in Pharmaceutical Nanotechnology at Mashhad University of Medical Sciences, Iran. Her research focuses on innovative drug delivery systems like nanoliposomes for treating cancer and eye diseases. With expertise in nanoformulations (liposome, micelle, polymer), she conducts in-vitro assays and specializes in MTT assay and HPLC. Her work spans biochemistry, immunology, and nanomedicine, highlighted by numerous publications on nanosensors, therapeutic nanoparticles, and drug delivery advancements. Dr. Mohammadzadeh is also skilled in statistical analysis, technical writing, and communication. She aims to revolutionize healthcare through cutting-edge pharmaceutical nanotechnology. πŸ“šπŸ’Š

 

Publication Profile

Professional Background

Dr. Vahideh Mohammadzadeh is currently pursuing her Ph.D. in Pharmaceutical Nanotechnology at Mashhad University of Medical Sciences, Iran. Her research primarily focuses on advancing drug delivery systems, particularly through nanotechnology. She specializes in the formulation of nanoliposomes and other nanostructures like micelles and polymers for targeted therapy in cancer and ocular diseases. Dr. Mohammadzadeh has extensive experience in conducting in-vitro biochemical and immunological assays, including MTT assay and HPLC analysis. Her work is underscored by a prolific publication record encompassing topics such as nanosensors, therapeutic nanoparticles, and innovative drug formulations. πŸ“ŠπŸ”¬

Education

Ph.D., Pharmaceutical Nanotechnology, Mashhad University of Medical Sciences, 2018-2024

M.Sc., Toxicology, Mashhad University of Medical Sciences, 2014-2017

B.Sc., Biology

Research Focus

Dr. Vahideh Mohammadzadeh’s research primarily focuses on advancing drug delivery systems in cancer therapy through innovative nanotechnologies. Her work spans the development and characterization of nanoliposomes, polymeric micelles, and other nanostructures to enhance the targeted delivery of therapeutic agents for cancer and ocular diseases. She explores novel formulations like liposomes and plant-based nanoparticles to optimize drug efficacy while minimizing side effects. Dr. Mohammadzadeh’s research also delves into nanosensors for biomolecule detection and the biological synthesis of nanoparticles for cytotoxicity studies. Her contributions aim to revolutionize healthcare through cutting-edge nanomedicine solutions. πŸŒŸπŸ”¬

 

Publication Top Notes

  • Poly-Ξ³-glutamic acid nanoparticles as adjuvant and antigen carrier system for cancer vaccination πŸ“„ Citations: 14 | Cited by: Jaafari, M.R. et al. | Year: 2023
  • Plant Gel-Mediated Synthesis of Gold-Coated Nanoceria Using Ferula gummosa: Characterization and Estimation of Its Cellular Toxicity toward Breast Cancer Cell Lines πŸ“„ Citations: 14 | Cited by: Sarafraz Ardakani, M.R. et al. | Year: 2023
  • Icariin: A Promising Natural Product in Biomedicine and Tissue Engineering πŸ“„ Citations: 22 | Cited by: Simal-Gandara, J. et al. | Year: 2023
  • Correction to: New insights into the application of nanoghosts as theranostic tools with an emphasis on cardiovascular diseases πŸ“„ Citations: 1 | Cited by: Qindeel, M. et al. | Year: 2022
  • Novel EPR-enhanced strategies for targeted drug delivery in pancreatic cancer: An update πŸ“„ Citations: 21 | Cited by: Sibuh, B.Z. et al. | Year: 2022
  • Fluorescent-based nanosensors for selective detection of a wide range of biological macromolecules: A comprehensive review πŸ“„ Citations: 106 | Cited by: DΓ­ez-Pascual, A.M. et al. | Year: 2022
  • Applications of plant-based nanoparticles in nanomedicine: A review πŸ“„ Citations: 84 | Cited by: Varma, R.S. et al. | Year: 2022
  • Biological synthesis and characterization of gold nanoparticles using Verbascum speciosum Schrad. and cytotoxicity properties toward HepG2 cancer cell line πŸ“„ Citations: 35 | Cited by: Nadaf, M. et al. | Year: 2022
  • Theranostic advances of bionanomaterials against gestational diabetes mellitus: A preliminary review πŸ“„ Citations: 24 | Cited by: Thakur, V.K. et al. | Year: 2021